4//SEC Filing
JOHNSON F ROSS 4
Accession 0001209191-08-043648
CIK 0000821616other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 5:28 PM ET
Size
25.8 KB
Accession
0001209191-08-043648
Insider Transaction Report
Form 4
JOHNSON F ROSS
Director
Transactions
- Disposition to Issuer
Option (Right to Buy)
2008-07-22−5,000→ 0 totalExercise: $9.90From: 2005-07-31Exp: 2015-05-24→ Common stock, $0.02 par value (5,000 underlying) - Disposition to Issuer
Common Stock, $0.02 par value
2008-07-22$14.82/sh−28,500$422,270→ 0 total
Footnotes (9)
- [F1]Disposed of in connection with the merger of Beryllium Merger Corporation ("Acquisition Sub") with and into Bentley Pharmaceuticals, Inc. ("Bentley"), effective July 22, 2008 (the "Effective Time"), (the "Merger"), pursuant to the Agreement and Plan of Merger, dated as of March 31, 2008, by and among Bentley, Teva Pharmaceutical Industries, Ltd. and Acquisition Sub (the "Merger Agreement"). In connection with the Merger, each share of Common Stock listed in Table I was exchanged for the right to receive $14.8165, per share in cash.
- [F2]This option was cancelled in the Merger in exchange for a cash payment of $24,565.00, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
- [F3]This option was cancelled in the Merger in exchange for a cash payment of $24,565.00, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
- [F4]This option was cancelled in the Merger in exchange for a cash payment of $24,565.00, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
- [F5]This option was cancelled in the Merger in exchange for a cash payment of $24,565.00, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
- [F6]This option was cancelled in the Merger in exchange for a cash payment of $16,691.00, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
- [F7]This option was cancelled in the Merger in exchange for a cash payment of $16,691.00, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
- [F8]This option was cancelled in the Merger in exchange for a cash payment of $16,691.00, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
- [F9]This option was cancelled in the Merger in exchange for a cash payment of $16,691.00, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
Documents
Issuer
BENTLEY PHARMACEUTICALS INC
CIK 0000821616
Entity typeother
Related Parties
1- filerCIK 0001209435
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 5:28 PM ET
- Size
- 25.8 KB